Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TAVR
MedTech
TCT: Boston Scientific's TAVR implant fails head-to-head study
Boston Scientific’s long-awaited Acurate neo2 missed its mark in a study aimed at bringing it to the U.S.—but the company believes it has a fix.
Conor Hale
Oct 30, 2024 11:55am
TCT: Using TAVR early helps prevent later hospitalizations
Oct 28, 2024 11:22am
Medtronic expands reach of latest TAVR valve with EU approval
Oct 24, 2024 1:00pm
FDA clears Pi-Cardia's leaflet splitter for valve-in-valve TAVR
Oct 1, 2024 2:00pm
Boston Scientific nets TAVR approval in Europe ahead of schedule
Aug 27, 2024 3:16pm
Medtronic’s head-to-head TAVR study shows benefits among women
Apr 9, 2024 12:26pm
